Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 127

1.

Brain metabolite alterations and cognitive dysfunction in early Huntington's disease.

Unschuld PG, Edden RA, Carass A, Liu X, Shanahan M, Wang X, Oishi K, Brandt J, Bassett SS, Redgrave GW, Margolis RL, van Zijl PC, Barker PB, Ross CA.

Mov Disord. 2012 Jun;27(7):895-902. doi: 10.1002/mds.25010. Epub 2012 May 30.

PMID:
22649062
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease.

Sturrock A, Laule C, Decolongon J, Dar Santos R, Coleman AJ, Creighton S, Bechtel N, Reilmann R, Hayden MR, Tabrizi SJ, Mackay AL, Leavitt BR.

Neurology. 2010 Nov 9;75(19):1702-10. doi: 10.1212/WNL.0b013e3181fc27e4. Erratum in: Neurology. 2011 Jan 18;76(3):309.

PMID:
21060093
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study.

Politis M, Pavese N, Tai YF, Kiferle L, Mason SL, Brooks DJ, Tabrizi SJ, Barker RA, Piccini P.

Hum Brain Mapp. 2011 Feb;32(2):258-70. doi: 10.1002/hbm.21008.

PMID:
21229614
[PubMed - indexed for MEDLINE]
4.

Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.

Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, Jones R, Landwehrmeyer GB, Fox NC, Johnson H, Hicks SL, Kennard C, Craufurd D, Frost C, Langbehn DR, Reilmann R, Stout JC; TRACK-HD Investigators.

Lancet Neurol. 2011 Jan;10(1):31-42. doi: 10.1016/S1474-4422(10)70276-3. Epub 2010 Dec 2.

PMID:
21130037
[PubMed - indexed for MEDLINE]
5.

The structural involvement of the cingulate cortex in premanifest and early Huntington's disease.

Hobbs NZ, Pedrick AV, Say MJ, Frost C, Dar Santos R, Coleman A, Sturrock A, Craufurd D, Stout JC, Leavitt BR, Barnes J, Tabrizi SJ, Scahill RI.

Mov Disord. 2011 Aug 1;26(9):1684-90. doi: 10.1002/mds.23747. Epub 2011 May 6.

PMID:
21557312
[PubMed - indexed for MEDLINE]
6.

Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.

Tabrizi SJ, Scahill RI, Owen G, Durr A, Leavitt BR, Roos RA, Borowsky B, Landwehrmeyer B, Frost C, Johnson H, Craufurd D, Reilmann R, Stout JC, Langbehn DR; TRACK-HD Investigators.

Lancet Neurol. 2013 Jul;12(7):637-49. doi: 10.1016/S1474-4422(13)70088-7. Epub 2013 May 9.

PMID:
23664844
[PubMed - indexed for MEDLINE]
7.

Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy.

Tandon N, Bolo NR, Sanghavi K, Mathew IT, Francis AN, Stanley JA, Keshavan MS.

Schizophr Res. 2013 Aug;148(1-3):59-66. doi: 10.1016/j.schres.2013.05.024. Epub 2013 Jun 20.

PMID:
23791389
[PubMed - indexed for MEDLINE]
8.

Prefrontal executive function associated coupling relates to Huntington's disease stage.

Unschuld PG, Liu X, Shanahan M, Margolis RL, Bassett SS, Brandt J, Schretlen DJ, Redgrave GW, Hua J, Hock C, Reading SA, van Zijl PC, Pekar JJ, Ross CA.

Cortex. 2013 Nov-Dec;49(10):2661-73. doi: 10.1016/j.cortex.2013.05.015. Epub 2013 Jun 26.

PMID:
23906595
[PubMed - indexed for MEDLINE]
9.

Defective emotion recognition in early HD is neuropsychologically and anatomically generic.

Henley SM, Wild EJ, Hobbs NZ, Warren JD, Frost C, Scahill RI, Ridgway GR, MacManus DG, Barker RA, Fox NC, Tabrizi SJ.

Neuropsychologia. 2008;46(8):2152-60. doi: 10.1016/j.neuropsychologia.2008.02.025. Epub 2008 Mar 6.

PMID:
18407301
[PubMed - indexed for MEDLINE]
10.

Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease.

Henley SM, Wild EJ, Hobbs NZ, Scahill RI, Ridgway GR, Macmanus DG, Barker RA, Fox NC, Tabrizi SJ.

J Neurol. 2009 Feb;256(2):203-12. doi: 10.1007/s00415-009-0052-x. Epub 2009 Mar 5.

PMID:
19266143
[PubMed - indexed for MEDLINE]
11.

Altered frontostriatal coupling in pre-manifest Huntington's disease: effects of increasing cognitive load.

Wolf RC, Sambataro F, Vasic N, Schönfeldt-Lecuona C, Ecker D, Landwehrmeyer B.

Eur J Neurol. 2008 Nov;15(11):1180-90. doi: 10.1111/j.1468-1331.2008.02253.x. Epub 2008 Aug 27.

PMID:
18754766
[PubMed - indexed for MEDLINE]
12.

Exploratory 7-Tesla magnetic resonance spectroscopy in Huntington's disease provides in vivo evidence for impaired energy metabolism.

van den Bogaard SJ, Dumas EM, Teeuwisse WM, Kan HE, Webb A, Roos RA, van der Grond J.

J Neurol. 2011 Dec;258(12):2230-9. doi: 10.1007/s00415-011-6099-5. Epub 2011 May 26.

PMID:
21614431
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.

Tabrizi SJ, Reilmann R, Roos RA, Durr A, Leavitt B, Owen G, Jones R, Johnson H, Craufurd D, Hicks SL, Kennard C, Landwehrmeyer B, Stout JC, Borowsky B, Scahill RI, Frost C, Langbehn DR; TRACK-HD investigators.

Lancet Neurol. 2012 Jan;11(1):42-53. doi: 10.1016/S1474-4422(11)70263-0. Epub 2011 Dec 2.

PMID:
22137354
[PubMed - indexed for MEDLINE]
14.

Depressive symptoms in prodromal Huntington's Disease correlate with Stroop-interference related functional connectivity in the ventromedial prefrontal cortex.

Unschuld PG, Joel SE, Pekar JJ, Reading SA, Oishi K, McEntee J, Shanahan M, Bakker A, Margolis RL, Bassett SS, Rosenblatt A, Mori S, van Zijl PC, Ross CA, Redgrave GW.

Psychiatry Res. 2012 Aug-Sep;203(2-3):166-74. doi: 10.1016/j.pscychresns.2012.01.002. Epub 2012 Sep 11.

PMID:
22974690
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.

Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RA, Durr A, Craufurd D, Kennard C, Hicks SL, Fox NC, Scahill RI, Borowsky B, Tobin AJ, Rosas HD, Johnson H, Reilmann R, Landwehrmeyer B, Stout JC; TRACK-HD investigators.

Lancet Neurol. 2009 Sep;8(9):791-801. doi: 10.1016/S1474-4422(09)70170-X. Epub 2009 Jul 29.

PMID:
19646924
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Heterogeneity in 1H-MRS profiles of presymptomatic and early manifest Huntington's disease.

Reynolds NC Jr, Prost RW, Mark LP.

Brain Res. 2005 Jan 7;1031(1):82-9.

PMID:
15621015
[PubMed - indexed for MEDLINE]
17.

Clinical correlation of striatal 1H MRS changes in Huntington's disease.

Sánchez-Pernaute R, García-Segura JM, del Barrio Alba A, Viaño J, de Yébenes JG.

Neurology. 1999 Sep 11;53(4):806-12.

PMID:
10489045
[PubMed - indexed for MEDLINE]
18.

Altered brain mechanisms of emotion processing in pre-manifest Huntington's disease.

Novak MJ, Warren JD, Henley SM, Draganski B, Frackowiak RS, Tabrizi SJ.

Brain. 2012 Apr;135(Pt 4):1165-79. doi: 10.1093/brain/aws024.

PMID:
22505631
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study.

Peinemann A, Schuller S, Pohl C, Jahn T, Weindl A, Kassubek J.

J Neurol Sci. 2005 Dec 15;239(1):11-9. Epub 2005 Sep 26.

PMID:
16185716
[PubMed - indexed for MEDLINE]
20.

Creatine supplementation lowers brain glutamate levels in Huntington's disease.

Bender A, Auer DP, Merl T, Reilmann R, Saemann P, Yassouridis A, Bender J, Weindl A, Dose M, Gasser T, Klopstock T.

J Neurol. 2005 Jan;252(1):36-41.

PMID:
15672208
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk